Toggle light / dark theme

Why hasn’t #MachineLearning conquered SARS-CoV-2 that causes COVID-19 (P.S., SARS-CoV-2 is the name of the #virus, while COVID-19 is the name of the disease)? One of the possible answers is that the virus “learns” faster than machines through “mutations”.

That causes us thinking: If mutation is such an efficient weapon (for virus), can we learn something from it and then apply our understanding to #DeepLearning to create “fast-mutating” #DeepLearning models capable of helping us to fight intractable crisis like a #pandemic?

https://bit.ly/3c9GE5s

Virus Mutation https://bit.ly/35xVvUQ

#COVID19 #AI #technology #innovation #NeuralNetworks


The remarkable capacity of some viruses to adapt to new hosts and environments is highly dependent on their ability to generate de novo diversity in a short period of time. Rates of spontaneous mutation vary amply among viruses. RNA viruses mutate faster than DNA viruses, single-stranded viruses mutate faster than double-strand virus, and genome size appears to correlate negatively with mutation rate. Viral mutation rates are modulated at different levels, including polymerase fidelity, sequence context, template secondary structure, cellular microenvironment, replication mechanisms, proofreading, and access to post-replicative repair. Additionally, massive numbers of mutations can be introduced by some virus-encoded diversity-generating elements, as well as by host-encoded cytidine/adenine deaminases. Our current knowledge of viral mutation rates indicates that viral genetic diversity is determined by multiple virus- and host-dependent processes, and that viral mutation rates can evolve in response to specific selective pressures.

SAN DIEGO, May 4, 2020 /PRNewswire/ — Global Institute of Stem Cell Therapy and Research (GIOSTAR), the worldwide leader in stem cell research, is pleased to announce that they have received an approval for a COVID-19 clinical trial, led by their Medical Director Dr. Prabhat Soni. GIOSTAR will conduct the trial using stem cells to treat COVID-19 patients, under the approval of the United States Food and Drug Administration (FDA) “expanded access for compassionate use” program. The Institute is exploring a promising alternative approach to the devastating disorder, which leverages the anti-inflammatory properties of mesenchymal stem cells (MSCs). According to Dr. Soni, the investigation is based upon two decades of stem cell research by GIOSTAR Co-Founder, Chairman and Chief Scientific Officer Dr. Anand Srivastava.

Rhesus macaques don’t monkey around when it comes to HIV; they have a protein that effectively disables invading HIV particles.

A group of University of Chicago scientists announced an innovative study that explains how the macaques’ immune protein, called TRIM5α, works its magic. It also represents a significant step forward in the science of modeling how complex biological proteins assemble themselves, the scientists said.

“These proteins work together to encase the HIV capsid in a hexagonal net and restrict viral activity,” said postdoctoral fellow Alvin Yu and lead author of the study, which was published in Nature Communications.

TRANSCRIPT AND MP3: www.corbettreport.com/gates

Who is Bill Gates? A software developer? A businessman? A philanthropist? A global health expert? This question, once merely academic, is becoming a very real question for those who are beginning to realize that Gates’ unimaginable wealth has been used to gain control over every corner of the fields of public health, medical research and vaccine development. And now that we are presented with the very problem that Gates has been talking about for years, we will soon find that this software developer with no medical training is going to leverage that wealth into control over the fates of billions of people.

Australian scientists work with medicine that can kill COVID-19 in 48 hours59.


“En tiempos en los que estamos teniendo una pandemia global y no hay un tratamiento aprobado, si tuviéramos un compuesto que ya estuviera disponible en todo el mundo, eso podría ayudar a la gente antes. Siendo realistas –consideró la investigadora-, pasará un tiempo antes de que una vacuna esté ampliamente disponible”.

Aunque no se conoce el mecanismo por el que la ivermectina actúa en el coronavirus, teniendo en cuenta su acción en otros virus, “es probable que funcione para detener la capacidad del virus de ‘amortiguar’ la capacidad de las células anfitrionas para eliminarlo”, dijo Wagstaff.

El uso de esta medicina para combatir la COVID-19 dependería, según la científica, de los resultados de más pruebas preclínicas y, en última instancia, de ensayos clínicos, con una financiación que se necesita urgentemente para seguir avanzando en el trabajo.

Deep Breathing alone will not create new lung cells, but combined with deep relaxation, guided visualizations, and therapeutic messages (Your stem cells are going to transform themselves into new lung cells to replace those lung cells infected by the Coronavirus. Your stem cells are going to change themselves into T-Cells, B-Cells, and Natural Killer Cells which are going to seek out, identify, attack, and destroy all the Coronavirus cells in your entire body), it will eliminate the coughing, fever, headaches, inflammation, and breathing problems.

While there is no hard evidence that lung exercises can help ease the discomfort and the progression of symptoms of COVID-19, there are techniques that will restore your lungs to optimal health.

ELON Musk shared the first photos of his newborn son with singer Grimes on Tuesday.

The Tesla CEO, 48, posted a cute snap of their sleeping baby using a face tattoo filter, as well as one of him cradling the newborn at the hospital on Twitter.

Responding to a fan who said their son is “gorgeous”, Elon joked about the tattoos: “Thanks smile Never too young for some ink haha.”

A study just released by Columbia University Mailman School of Public Health is reporting a blood-DNA-methylation measure that is sensitive to variation in the pace of biological aging among individuals born the same year. The tool—DunedinPoAm—offers a unique measurement for intervention trials and natural experiment studies investigating how the rate of aging may be changed by behavioral or drug therapy, or by changes to the environment. The study findings are published online in the journal eLife.

“The goal of our study was to distill a measurement of the rate of biological aging based on 12-years of follow-up on 18 different clinical tests into a blood test that can be administered at a single time point.” said lead author Daniel Belsky, Ph.D., assistant professor of epidemiology at Columbia Mailman School and a researcher at the Columbia Aging Center.

Midlife adults measured to be aging faster according to the new measurement showed faster declines in physical and cognitive functioning and looked older in facial photographs. Older adults measured to be aging faster by the tool were at increased risk for chronic disease and mortality. In other analyses, the researchers showed that DunedinPoAm captured new information not measured by proposed measures of biological aging known as epigenetic clocks, that 18-year-olds with histories of childhood poverty and victimization showed faster aging as measured by DunedinPoAm, and that DunedinPoAm predictions were disrupted by a caloric restriction intervention in a randomized trial.